RT Journal Article
SR Electronic
T1 Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000870
DO 10.1136/jitc-2020-000870
VO 8
IS 2
A1 Naing, Aung
A1 Eder, Joseph P
A1 Piha-Paul, Sarina A
A1 Gimmi, Claude
A1 Hussey, Elizabeth
A1 Zhang, Sen
A1 Hildebrand, Vera
A1 Hosagrahara, Vinayak
A1 Habermehl, Christina
A1 Moisan, Jacques
A1 Papadopoulos, Kyriakos P
YR 2020
UL http://jitc.bmj.com/content/8/2/e000870.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.